At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Nov 11, 2008 bloch stephen m Director Automatic Sell 3,000 9.20
Apr 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 9.13
Nov 18, 2008 bloch stephen m Director Automatic Sell 3,000 9.11
Feb 1, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 32,100 9.09 - 9.44
Feb 1, 2008 topper james n Director Buy 32,100 9.09 - 9.44
Nov 7, 2008 bloch stephen m Director Automatic Sell 3,000 9.08
Nov 19, 2008 bloch stephen m Director Automatic Sell 3,000 9.03
Nov 17, 2008 bloch stephen m Director Automatic Sell 7,740 9.02
Feb 1, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 5,600 9.01 - 9.08
Feb 1, 2008 topper james n Director Buy 5,600 9.01 - 9.08
Nov 10, 2008 bloch stephen m Director Automatic Sell 3,000 8.98
May 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 8.95
Dec 1, 2008 bloch stephen m Director Automatic Sell 4 8.90
Oct 27, 2008 bloch stephen m Director Automatic Sell 2,942 8.89
Nov 20, 2008 bloch stephen m Director Automatic Sell 3,000 8.83
Oct 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 8.75
Feb 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 8.69
Dec 8, 2008 bloch stephen m Director Automatic Sell 3,000 8.54
Nov 24, 2008 bloch stephen m Director Automatic Sell 3,000 8.52
Nov 26, 2008 bloch stephen m Director Automatic Sell 3,000 8.52
Showing 281-300 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy